Track SLU‑PP‑332 in Peptimes™
SLU-PP-332 is a small-molecule chemical, not a peptide: 4-hydroxybenzoic acid 2-(2-naphthalenylmethylene)hydrazide, with the formula C18H14N2O2. (Source: FDA's substance registry (GSRS).)
Is SLU-PP-332 FDA-approved?
No. SLU-PP-332 isn't FDA-approved: Drugs@FDA lists no application with it as an active ingredient.
SLU-PP-332
Also: 4-hydroxybenzoic acid 2-(2-naphthalenylmethylene)hydrazide
- Status label in the Peptimes Library
- Not FDA-Approved
- Routes in Peptimes
- SubcutaneousIntramuscularOralSublingualNasalTopicalOther
- Updated
- 1 Nov 2026
US regulatory status
How to track it in Peptimes
Add SLU-PP-332 in My Protocols and set the schedule you already follow: days of the week, times of day and a start date. Peptimes never suggests an amount when you log or schedule a dose. Its Library entry shows the status label “Not FDA-Approved”.
- Routes: its route isn’t established in people, so you can choose any route the app offers. Choose the one that matches each dose.
- Logging: the amount you took, the route and how you feel.
- Injection sites: injected doses record the site, and Insights shows where you’ve injected and how recently. It never suggests where to inject next. Other routes skip this step.
- Reminders and history: reminders at your times, Dose History, the Calendar and CSV or JSON export work as described on the peptide tracker app page.
Peptimes is a tracking app, not medical advice. Talk to a licensed clinician about your treatment. Peptimes doesn’t sell SLU-PP-332 or any other compound.
More sources
- FDA, Drugs@FDA, checked 1 Nov 2026: no application lists SLU-PP-332 as an active ingredient.
- NIH, ClinicalTrials.gov, studies of SLU-PP-332, checked 1 Nov 2026: no registered study.
- FDA, Global Substance Registration System, SLU-PP-332, checked 1 Nov 2026: its chemical name and formula.